4.7 Article Proceedings Paper

Spontaneous immune responses to sporadic tumors: tumor-promoting, tumor-protective or both?

Journal

CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume 57, Issue 10, Pages 1531-1539

Publisher

SPRINGER
DOI: 10.1007/s00262-008-0501-x

Keywords

inflammation; cancer; innate immune system; adaptive immune system; immunosurveillance

Ask authors/readers for more resources

Cancer cells cannot develop into invasive cancers without interactions with cells and soluble mediators present in the tumor microenvironment. Accumulating evidence indicates that the immune system is a critical determinant of malignant outgrowth; however, the tumor-modulating effects of spontaneous immune responses towards nascent malignancies are rather paradoxical. Both cancer-protective and cancer-promoting features of the immune system have been described. This review will discuss the role of the dynamic inflammatory tumor microenvironment during cancer development and progression, and will focus on the intriguing question: Do malignancies develop in spite of-or because of-spontaneous immune responses? Special emphasis will be put on recent progress in our understanding of the immune system's double-edged sword function during de novo carcinogenesis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Editorial Material Oncology

Pulling the Strings of the Tumor Microenvironment

Claudia Burrello, Karin E. de Visser

Summary: Macrophages are a focal point of cancer immunotherapy research due to their significant role in promoting tumor growth. A recent study found that targeting macrophages can influence the tumor microenvironment and lead to coordinated antitumorigenic immune responses in a lung carcinoma mouse model.

CANCER IMMUNOLOGY RESEARCH (2022)

Review Immunology

Neutrophil phenotypes and functions in cancer: A consensus statement

Daniela F. Quail, Borko Amulic, Monowar Aziz, Betsy J. Barnes, Evgeniy Eruslanov, Zvi G. Fridlender, Helen S. Goodridge, Zvi Granot, Andres Hidalgo, Anna Huttenlocher, Mariana J. Kaplan, Ilaria Malanchi, Taha Merghoub, Etienne Meylan, Vivek Mittal, Mikael J. Pittet, Andrea Rubio-Ponce, Irina A. Udalova, Timo K. van den Berg, Denisa D. Wagner, Ping Wang, Arturo Zychlinsky, Karin E. de Visser, Mikala Egeblad, Paul Kubes

Summary: This article discusses the functional states and heterogeneity of neutrophils in cancer and provides a consensus statement on the controversies and solutions in neutrophil research. Further research is needed to understand the role of neutrophils in cancer and explore potential novel opportunities for cancer treatment.

JOURNAL OF EXPERIMENTAL MEDICINE (2022)

Article Cell Biology

Tumor-educated Tregs drive organ-specific metastasis in breast cancer by impairing NK cells in the lymph node niche

Kevin Kos, Muhammad A. Aslam, Rieneke van de Ven, Max D. Wellenstein, Wietske Pieters, Antoinette van Weverwijk, Danique E. M. Duits, Kim van Pul, Cheei-Sing Hau, Kim Vrijland, Daphne Kaldenbach, Elisabeth A. M. Raeven, Sergio A. Quezada, Rudi Beyaert, Heinz Jacobs, Tanja D. de Gruijl, Karin E. de Visser

Summary: Breast cancer causes systemic immunosuppression, which affects the organotropism of metastasis. Tumor-educated regulatory T cells (T-regs) accumulate in distant organs and undergo transcriptional rewiring in response to mammary tumorigenesis. T-regs control natural killer (NK) cell activation in lymph nodes, thereby promoting lymph node metastasis. The ratio of T-regs to NK cells is increased in sentinel lymph nodes of breast cancer patients compared to healthy controls.

CELL REPORTS (2022)

Article Oncology

Tumor-associated macrophages promote intratumoral conversion of conventional CD4+ T cells into regulatory T cells via PD-1 signalling

Kevin Kos, Camilla Salvagno, Max D. Wellenstein, Muhammad A. Aslam, Denize A. Meijer, Cheei-Sing Hau, Kim Vrijland, Daphne Kaldenbach, Elisabeth A. M. Raeven, Martina Schmittnaegel, Carola H. Ries, Karin E. de Visser

Summary: This study reveals that tumor-associated macrophages (TAMs) contribute to the accumulation of regulatory T cells (T-regs) in breast tumors by promoting the conversion of CD4(+) T cells into T-regs. It is found that TAMs directly promote the conversion of CD4(+) T cells into T-regs through TGF-beta, and indirectly enhance the accumulation of T-regs by enhancing PD-1 expression on CD4(+) T cells.

ONCOIMMUNOLOGY (2022)

Article Oncology

Comprehensive multiplexed immune profiling of the ductal carcinoma in situ immune microenvironment regarding subsequent ipsilateral invasive breast cancer risk

Mathilde M. Almekinders, Tycho Bismeijer, Tapsi Kumar, Fei Yang, Bram Thijssen, Rianne van der Linden, Charlotte van Rooijen, Shiva Vonk, Baohua Sun, Edwin R. Parra Cuentas, Ignacio I. Wistuba, Savitri Krishnamurthy, Lindy L. Visser, Iris M. Seignette, Ingrid Hofland, Joyce Sanders, Annegien Broeks, Jason K. Love, Brian Menegaz, Lodewyk Wessels, Alastair M. Thompson, Karin E. de Visser, Erik Hooijberg, Esther Lips, Andrew Futreal, Jelle Wesseling

Summary: Through a study on a Dutch population-based cohort of 10,090 women with pure DCIS, it was found that IME features are not predictors of subsequent ilBC, but correlate with other factors (grade, ER, HER2 status, Ki-67) known to be associated with invasive recurrences.

BRITISH JOURNAL OF CANCER (2022)

Editorial Material Immunology

The lung fibroblast as soil fertilizer'' in breast cancer metastasis

Julia M. Houthuijzen, Karin E. de Visser

Summary: Breast cancer cells exploit lung-specific immunosuppressive fibroblasts to facilitate metastasis.

IMMUNITY (2022)

Article Cell Biology

hMRP8-ATTAC Mice: A New Model for Conditional and Reversible Neutrophil Ablation

Danique E. M. Duits, Camilla Salvagno, Elisabeth A. M. Raeven, Kim Vrijland, Marjolein C. Stip, Cheei-Sing Hau, Daphne Kaldenbach, Karin E. de Visser

Summary: Neutrophils play critical roles in infections, tissue repair, and cancer. Several methods, including neutralizing antibodies, CXCR2 inhibitors, and the ATTAC approach, have been used to investigate their in vivo functions. The newly generated hMRP8-ATTAC mouse model efficiently reduces neutrophil levels under homeostatic conditions.

CELLS (2022)

Article Multidisciplinary Sciences

MYC promotes immune-suppression in triple-negative breast cancer via inhibition of interferon signaling

Dario Zimmerli, Chiara S. Brambillasca, Francien Talens, Jinhyuk Bhin, Renske Linstra, Lou Romanens, Arkajyoti Bhattacharya, Stacey E. P. Joosten, Ana Moises Da Silva, Nuno Padrao, Max D. Wellenstein, Kelly Kersten, Mart de Boo, Maurits Roorda, Linda Henneman, Roebi de Bruijn, Stefano Annunziato, Eline van der Burg, Anne Paulien Drenth, Catrin Lutz, Theresa Endres, Marieke van de Ven, Martin Eilers, Lodewyk Wessels, Karin E. de Visser, Wilbert Zwart, Rudolf S. N. Fehrmann, Marcel A. T. M. van Vugt, Jos Jonkers

Summary: MYC plays a crucial role in suppressing anti-tumour immunity in triple-negative breast cancer by directly regulating the transcription of interferon signalling genes. MYC overexpression decreases lymphocyte infiltration in tumors and prevents the recruitment and activation of immune cells. These findings reveal the mechanisms by which MYC overexpression leads to poor immunogenicity in triple-negative breast cancer.

NATURE COMMUNICATIONS (2022)

Article Oncology

IL-5-producing CD4(+) T cells and eosinophils cooperate to enhance response to immune checkpoint blockade in breast cancer

Olga S. Blomberg, Lorenzo Spagnuolo, Hannah Garner, Leonie Voorwerk, Olga I. Isaeva, Ewald van Dyk, Noor Bakker, Myriam Chalabi, Chris Klaver, Maxime Duijst, Kelly Kersten, Marieke Bruggemann, Dorien Pastoors, Cheei-Sing Hau, Kim Vrijland, Elisabeth A. M. Raeven, Daphne Kaldenbach, Kevin Kos, Inna S. Afonina, Paulien Kaptein, Louisa Hoes, Willemijn S. M. E. Theelen, Paul Baas, Emile E. Voest, Rudi Beyaert, Daniela S. Thommen, Lodewyk F. A. Wessels, Karin E. de Visser, Marleen Kok

Summary: Immune checkpoint blockade (ICB) has revolutionized cancer therapy by promoting effective immune responses through the activation of CD4(+) T cells and the recruitment of eosinophils. This study demonstrates the critical role of eosinophils in ICB response and provides proof-of-principle for enhancing ICB efficacy through eosinophil engagement. Mechanistically, ICB increases IL-5 production, stimulating elevated eosinophil production and systemic eosinophil expansion.

CANCER CELL (2023)

Article Cell Biology

Immunoediting instructs tumor metabolic reprogramming to support immune evasion

Chin-Hsien Tsai, Yu-Ming Chuang, Xiaoyun Li, Yi-Ru Yu, Sheue-Fen Tzeng, Shao Thing Teoh, Katherine E. Lindblad, Mario Di Matteo, Wan-Chen Cheng, Pei-Chun Hsueh, Kung-Chi Kao, Hana Imrichova, Likun Duan, Hector Gallart-Ayala, Pei-Wen Hsiao, Massimiliano Mazzone, Julijana Ivanesevic, Xiaojing Liu, Karin E. de Visser, Amaia Lujambio, Sophia Y. Lunt, Susan M. Kaech, Ping-Chih Ho

Summary: T cell-mediated immunosurveillance in early-stage tumorigenesis guides metabolic reprogramming in tumor cells through non-canonical interferon gamma (IFNg)-STAT3 signaling, leading to immune evasion and the formation of a suppressive tumor microenvironment.

CELL METABOLISM (2023)

Review Oncology

The evolving tumor microenvironment From cancer initiation to metastatic outgrowth

Karin E. de Visser, Johanna A. Joyce

Summary: Cancers consist of tumor cells and various non-cancerous cells in an altered extracellular matrix, forming complex ecosystems. The tumor microenvironment (TME) includes different immune cell types, cancer-associated fibroblasts, endothelial cells, pericytes, and other tissue-resident cells, all of which play critical roles in cancer pathogenesis. The composition and function of the TME can vary depending on the organ, cancer cell features, tumor stage, and patient characteristics. Understanding the interplay between tumor cell-intrinsic, cell-extrinsic, and systemic factors is crucial for developing effective anti-cancer treatments.

CANCER CELL (2023)

Article Oncology

Neoadjuvant immune checkpoint blockade triggers persistent and systemic Treg activation which blunts therapeutic efficacy against metastatic spread of breast tumors

Olga S. S. Blomberg, Kevin Kos, Lorenzo Spagnuolo, Olga I. I. Isaeva, Hannah Garner, Max D. D. Wellenstein, Noor Bakker, Danique E. M. Duits, Kelly Kersten, Sjoerd Klarenbeek, Cheei-Sing Hau, Daphne Kaldenbach, Elisabeth A. M. Raeven, Kim Vrijland, Marleen Kok, Karin E. E. de Visser

Summary: The use of immune checkpoint blockade (ICB) therapy in neoadjuvant and perioperative settings is gaining attention due to its clinical successes in advanced cancer patients. However, the impact of neoadjuvant ICB therapy on systemic immune landscape and metastatic spread is still uncertain. Tumors promote the expansion of regulatory T cells (T-regs), which suppress the immune response and contribute to tumor progression and metastasis. This study demonstrates that neoadjuvant ICB therapy in breast cancer patients inadvertently promotes the proliferation and activation of T-regs, which can counteract the efficacy of ICB therapy. By depleting T-regs, the intratumoral immune landscape becomes favorable for ICB response and induces lasting alterations in systemic immunity, leading to extended metastasis-related survival driven by CD8+ T cells.

ONCOIMMUNOLOGY (2023)

Article Oncology

PD-L1 blockade in combination with carboplatin as immune induction in metastatic lobular breast cancer: the GELATO trial

Leonie Voorwerk, Olga I. I. Isaeva, Hugo M. M. Horlings, Sara Balduzzi, Maksim Chelushkin, Noor A. M. Bakker, Elisa Champanhet, Hannah Garner, Karolina Sikorska, Claudette E. E. Loo, Inge Kemper, Ingrid A. M. Mandjes, Michiel de Maaker, Jasper J. L. van Geel, Jorianne Boers, Maaike de Boer, Roberto Salgado, Marloes G. J. van Dongen, Gabe S. S. Sonke, Karin E. E. de Visser, Ton N. N. Schumacher, Christian U. U. Blank, Lodewyk F. A. Wessels, Agnes Jager, Vivianne C. G. Tjan-Heijnen, Carolien P. Schroder, Sabine C. C. Linn, Marleen Kok

Summary: This study found that invasive lobular breast cancer is the second most common subtype of breast cancer, but there is a lack of specific clinical trials for this type. They identified an immune-related subset of lobular breast cancer and observed synergy between immune checkpoint blockade and platinum in mouse models. In the GELATO trial, treatment with carboplatin and atezolizumab showed promising antitumor activity, especially for triple-negative lobular breast cancer.

NATURE CANCER (2023)

Article Oncology

Poor Outcome in Postpartum Breast Cancer Patients Is Associated with Distinct Molecular and Immunologic Features

Hanne Lefrere, Kat Moore, Giuseppe Floris, Joyce Sanders, Iris M. Seignette, Tycho Bismeijer, Dennis Peters, Annegien Broeks, Erik Hooijberg, Kristel Van Calsteren, Patrick Neven, Ellen Warner, Fedro Alessandro Peccatori, Sibylle Loibl, Charlotte Maggen, Sileny N. Han, Katarzyna J. Jerzak, Daniela Annibali, Diether Lambrechts, Karin E. de Visser, Lodewyk Wessels, Liesbeth Lenaerts, Frederic Amant

Summary: Patients with postweaning postpartum breast cancer (PP-BCPW) have a poor prognosis compared with other types of breast cancer. This study found that PP-BCPW patients with low expression of immunoglobulin genes but high infiltration of plasma B cells have an increased risk of metastasis and death.

CLINICAL CANCER RESEARCH (2023)

Review Oncology

Mechanisms driving the immunoregulatory function of cancer cells

Antoinette van Weverwijk, Karin E. E. de Visser

Summary: Tumours exhibit a wide range of variations in the distribution, composition, and activation state of immune cells, which affect their progression and response to immunotherapy. Understanding the mechanisms that regulate the diversity and function of immune cells in the tumour microenvironment will lead to the development of more targeted immunomodulatory strategies for the benefit of cancer patients.

NATURE REVIEWS CANCER (2023)

No Data Available